Adaptive Biotechnologies Corp (ADPT) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$277.0M

Net Income/Loss (FY2025)

-$59.5M

Total Assets (FY2025)

$512.7M

Total Equity (FY2025)

$225.0M

Cash Flows from Operating Activities (FY2025)

-$46.0M

Source: Adaptive Biotechnologies Corp 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.